These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 29657199

  • 1. Impact of body mass index on progression of primary immunoglobulin a nephropathy.
    Nagaraju SP, Rangaswamy D, Mareddy AS, Prasad S, Kaza S, Shenoy S, Saraf K, Attur RP, Parthasarathy R, Kosuru S, Mateti UV, Guddattu V, Koulmane Laxminarayana SL.
    Saudi J Kidney Dis Transpl; 2018; 29(2):318-325. PubMed ID: 29657199
    [Abstract] [Full Text] [Related]

  • 2. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C, Wang AY, Li G, Wang L.
    BMC Nephrol; 2018 Dec 29; 19(1):381. PubMed ID: 30594167
    [Abstract] [Full Text] [Related]

  • 3. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 29; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 4. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 5. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate.
    Okonogi H, Utsunomiya Y, Miyazaki Y, Koike K, Hirano K, Tsuboi N, Suzuki T, Hara Y, Ogura M, Hosoya T, Kawamura T.
    Nephron Clin Pract; 2011 Jun 06; 118(3):c292-300. PubMed ID: 21212693
    [Abstract] [Full Text] [Related]

  • 6. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov 06; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 7. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar 06; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 8. Body mass index and the risk of progression of chronic kidney disease.
    Khedr A, Khedr E, House AA.
    J Ren Nutr; 2011 Nov 06; 21(6):455-61. PubMed ID: 21454093
    [Abstract] [Full Text] [Related]

  • 9. Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy.
    Berthoux F, Mariat C, Maillard N.
    Nephrol Dial Transplant; 2013 Nov 06; 28 Suppl 4():iv160-6. PubMed ID: 24026246
    [Abstract] [Full Text] [Related]

  • 10. Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy.
    Ouyang Y, Xie J, Yang M, Zhang X, Ren H, Wang W, Chen N.
    PLoS One; 2016 Nov 06; 11(9):e0162044. PubMed ID: 27611091
    [Abstract] [Full Text] [Related]

  • 11. Association between urinary C4d levels and disease progression in IgA nephropathy.
    Dong Y, Wang Z, Guo W, Zhu L, Zhou X, Shi S, Liu L, Lv J, Zhang H.
    Nephrol Dial Transplant; 2024 Jul 31; 39(8):1279-1287. PubMed ID: 38178632
    [Abstract] [Full Text] [Related]

  • 12. Association of obesity with the development of end stage renal disease in IgA nephropathy patients.
    Wang S, Qin A, Dong L, Tan J, Zhou X, Qin W.
    Front Endocrinol (Lausanne); 2023 Jul 31; 14():1094534. PubMed ID: 37020590
    [Abstract] [Full Text] [Related]

  • 13. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W.
    Front Immunol; 2021 Jul 31; 12():700224. PubMed ID: 34456912
    [Abstract] [Full Text] [Related]

  • 14. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R, Ferjuc A, Furman B, Gerjevič Š, Bevc S, Hojs R.
    Ther Apher Dial; 2013 Aug 31; 17(4):363-7. PubMed ID: 23931872
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 31; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 16. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar 31; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 17. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr 31; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 18. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
    Sato Y, Tsukaguchi H, Higasa K, Kawata N, Inui K, Linh TNT, Quynh TTH, Yoshihiko I, Koiwa F, Yoshimura A.
    BMC Nephrol; 2021 Jun 19; 22(1):230. PubMed ID: 34147067
    [Abstract] [Full Text] [Related]

  • 19. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan 30; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.